New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Pfizer Eyes Full FDA Approval for Covid-19 Vaccine

Pfizer and partner BioNTech are the first vaccine manufacturers to seek full approval in the U.S.

A recent Politico article noted that Pfizer and its partner BioNTech are seeking full approval from the FDA for their Covid-19 vaccine for people 16 and older. The two-dose protection against coronavirus received emergency use authorization earlier this year, which allowed it to be one of three vaccines used in the pandemic battle. Full approval means the companies would be able to market the shot directly to consumers, and make it easier for schools, employers, and the military to require vaccination against Covid-19.

In addition, Pfizer and BioNTech are also seeking an expansion of their emergency use authorization to allow their shots to be used on people ages 12-15. The U.S. has already bought 400 million doses of Pfizer’s vaccine, making it the leader in U.S. shots. The companies are now researching vaccine use on children as young as 6 months. Results for this are expected to emerge in September. 

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub